Anuncian un acuerdo de distribución de Zemcelpro® para Argentina, Hong Kong y Singapur

PartnershipZemcelproPositive

AI Analysis

Summary

FarmaMondo has secured distribution rights for Zemcelpro (dorocubicel), a European Commission conditionally authorized cell therapy for hematologic neoplasms, in Argentina, Hong Kong, and Singapur.

Importance:5/10

Sentiment:

0.60

distribution agreementZemcelprocell therapygeographic expansionArgentinaHong KongSingapur

Read the original article

Published by PR Newswire Biotech on July 16, 2026 1:45 PM

Read Original